Join our latest Webinar about EUDAMED. Sandra Ferretti, CCO at Obelis Group will walk you through all the challenges related to Actor and Device Registration!
Join our latest Webinar about EUDAMED. Sandra Ferretti, CCO at Obelis Group will walk you through all the challenges related to Actor and Device Registration!
Rapid antigen tests are widely used in the European Union and are helping to strengthen many countries testing capacities. For more information visit our page!
Antigen tests are IVDs of class D under the IVDR. This means that they will fall under the highest-risk category of IVDs, needing a Notified Body involvement.
Within the model of the EU circular economy, the economic operators have to comply with the WEEE Directive. Discover all the details in our article!
In February 2022, Obelis Group acquires SYNC Projects and expands its operations to the Israeli market, securing compliance in a new territory.
The European Commission rolled out a new Standardisation Strategy that will be relevant on a global scale. Visit our page for more information.
The introduction of the new Regulations on medical devices in the European Union meant stricter controls and reinforced rules on transparency and clinical evidence. Learn more!
The elimination of barriers and the introduction of free movement of goods, services, and people across the Member States have granted a more dynamic business environment. To learn about the consequences of these new changes visit our page!
In 2008, the European Parliament and the Council jointly adopted the Decision No. 768/2008/EC aiming to set a common framework for a new Industrial Policy. Read more
With the In Vitro Diagnostic Medical Devices Regulation (IVDR), the IVD sector in the European Union is about to experience significant changes. From a new classification system to stricter assessment procedures and market surveillance. Read the full article to discover all the details!